Multidrug resistance in ocular melanoma

British Journal of Ophthalmology

Volumn 80, Issue 11, 1996, Pages 1009-1012

  McNamara, M ^a   Clynes, M ^b   Dunne, B ^a   NicAmhlaoibh, R ^b   Lee, W R ^c   Barnes, C ^a   Kennedy, S M ^a  

^a ROYAL VICTORIA EYE AND EAR HOSPITAL   (Ireland)

^b DUBLIN CITY UNIVERSITY   (Ireland)

^c WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; EYE CANCER; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

EID: 0029847869     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.80.11.1009     Document Type: Article

References (21)

1. McCartney AC. Pathology of ocular melanomas. Br Med Bull 1995;51:678-93.
2. De Potter P, Shields CL, Shields JA, Cater JR, Tardio DJ. Impact of enucleation versus plaque radiotherapy in the management of juxtapapillary choroidal melanoma on patient survival. Br J Ophthalmol 1994;78:109-14.
3. Kath R, Hayungs J, Bornfeld N, Sauerwein W, Hofften K, Seeber S. Prognosis and treatment of disseminated uveal melanoma. Cancer 1993;72:2219-23.
4. Rajpal S, Moore R, Karakousis CP. Survival in metastatic ocular melanoma. Cancer 1983;52:334-6.
5. Bedikian AY, Kantarjian H, Young SE, Bodey GP. Prognosis in metastatic choroidal melanoma. South Med J 1981;74: 574-7.
6. Einhorn LH, Burgess MA, Gottlieb JA. Metastatic patterns of choroidal melanoma. Cancer 1974;34:1001-4.
7. Weinstein RS, Kuszak JR, Kluskens LF, Coon JS. P-glycoproteins in pathology: the multidrug resistance gene family in humans. Hum Pathol 1990;21:34-48.
8. Schinkel AH, Arceci RJ, Smit JJ, Wagenaar E, Baas F, Dolle M, et al. Binding properties of monoclonal antibodies recognising external epitopes of the human MDR1 P-glycoprotein. Int J Cancer 1993;55:478-84.
9. Hsu SM, Raine L, Fanger H. Use of avidin biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-80.
10. O'Driscoll L, Daly C, Saleh M, Clynes M. The use of reverse transcriptase-polymerase chain reaction (RT-PCR) to investigate specific gene expression in multidrug-resistant cells. Cytotechnology 1993;12:289-314.
11. O'Driscoll L, Kennedy S, McDermott E, Kelehan P, Clynes M. Multiple drug resistance-related messenger RNA in archival formalin-fixed paraffin-embedded human breast tumour tissue. Eur J Cancer 1996;32A:128-33.
12. Schadendorf D, Herfordt R, Czarnetzki BM. P-glycoprotein expression in primary and metastatic malignant melanoma. Br J Dermatol 1995;132:551-5.
13. Levine EA, Holzmayer TA, Roninson IB, Das Gupta TK. MDR-1 expression in metastatic malignant melanoma. J Surg Res 1993;54:621-4.
14. Wishart GC, Plumb JA Going JJ, McNicol AM, McArdle CS, Tsuruo T, et al. P-glycoprotein expression in primary breast cancer detected by immunocytochemistry with two monoclonal antibodies. Br J Cancer 1990;62:758-61.
15. Davidorf FH, Lang JR. The natural history of malignant melanoma of the choroid: small versus large tumors. Trans Am Acad Ophthalmol Otolaryngol 1975;79:OP310-20.
16. McLean IW, Foster WD, Zimmerman LE. Prognostic factors in small malignant melanomas of the choroid and ciliary body. Arch Ophthalmol 1977;95:48-58.
17. Shammas HF, Blodi FC. Prognostic factors in choroidal and ciliary body melanomas. Arch Ophthalmol 1977;95:63-9.
18. Kidd MN, Lyness RW, Patterson CC, Johnston PB, Archer DB. Prognostic factors in malignant melanoma of the choroid: a retrospective survey of cases occurring in Northern Ireland between 1965 and 1980. Trans Ophthalmol Soc UK 1986;105:114-21.
19. Baldini N, Scotlandi K, Barbanti-Brodano G, Manara MC, Maurici D, Bacci G, et al. Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome. N Engl J Med 1995;333:1380-5.
20. Roessner A, Ueda Y, Bockhorn-Dworniczak B, Blasius S, Peters A, Wuisman P, et al. Prognostic implication of immunodetection of P glycoprotein in Ewing's sarcoma. J Cancer Res Clin Oncol 1993;119:185-9.
21. Norris MD, Bordow SB, Marshall GM, Haber PS, Cohn SL, Haber M. Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma. N Engl J Med 1996;334:231-8.